Learning MRI-based classification models for MGMT methylation status prediction in glioblastoma

Computer Methods and Programs in Biomedicine

Volumn 140, Issue , 2017, Pages 249-257

  Kanas, Vasileios G ^a   Zacharaki, Evangelia I ^a,b   Thomas, Ginu A ^c   Zinn, Pascal O ^d   Megalooikonomou, Vasileios ^a   Colen, Rivka R ^c  

^a UNIVERSITY OF PATRAS   (Greece)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Feature extraction; Glioblastoma; MGMT promoter methylation; Multivariate analysis; Prediction model

Indexed keywords

ALKYLATION; CHEMOTHERAPY; FEATURE EXTRACTION; FORECASTING; LEARNING SYSTEMS; MAGNETIC RESONANCE IMAGING; MULTIVARIANT ANALYSIS; TUMORS;

EXPERIMENTAL ANALYSIS; GLIOBLASTOMAS; MACHINE LEARNING METHODS; MULTI VARIATE ANALYSIS; PREDICTION MODEL; PROMOTER METHYLATION; RETROSPECTIVE ANALYSIS; SIGNIFICANT VARIABLES;

METHYLATION;

METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; DNA LIGASE; DNA METHYLTRANSFERASE; MGMT PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER LOCALIZATION; CANCER PATIENT; CANCER SIZE; CONTROLLED STUDY; DNA METHYLATION; FEMALE; GENETIC DATABASE; GLIOBLASTOMA; HUMAN; MACHINE LEARNING; MAJOR CLINICAL STUDY; MALE; MGMT GENE; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOGENE; PREOPERATIVE EVALUATION; PROMOTER REGION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; BRAIN TUMOR; DIAGNOSTIC IMAGING; GENETICS; METABOLISM; MIDDLE AGED; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; DNA METHYLATION; DNA MODIFICATION METHYLASES; DNA REPAIR ENZYMES; FEMALE; GLIOBLASTOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROMOTER REGIONS, GENETIC; TUMOR SUPPRESSOR PROTEINS; YOUNG ADULT;

EID: 85008173453     PISSN: 01692607     EISSN: 18727565     Source Type: Journal    
DOI: 10.1016/j.cmpb.2016.12.018     Document Type: Article

References (58)

1. [1] Weller, M., Stupp, R., Reifenberger, G., Brandes, A.A., van den Bent, M.J., Wick, W., Hegi, M.E., MGMT promoter methylation in malignant gliomas: ready for personalized medicine?. Nat. Rev. Neurol. 6:1 (2010), 39–51.
2. [2] Wick, W., Hartmann, C., Engel, C., Stoffels, M., Felsberg, J., Stockhammer, F., Sabel, M.C., Koeppen, S., Ketter, R., Meyermann, R., NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide. J. Clin. Oncol. 27:35 (2009), 5874–5880.
3. [3] Hegi, M.E., Diserens, A.-C., Gorlia, T., Hamou, M.-F., de Tribolet, N., Weller, M., Kros, J.M., Hainfellner, J.A., Mason, W., Mariani, L., MGMT gene silencing and benefit from temozolomide in glioblastoma. N. Engl. J. Med. 352:10 (2005), 997–1003.
4. [4] Donson, A.M., Addo‐Yobo, S.O., Handler, M.H., Gore, L., Foreman, N.K., MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastoma. Pediatr. Blood Cancer 48:4 (2007), 403–407.
5. [5] Dunn, J., Baborie, A., Alam, F., Joyce, K., Moxham, M., Sibson, R., Crooks, D., Husband, D., Shenoy, A., Brodbelt, A., Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy. Br. J. Cancer. 101:1 (2009), 124–131.
6. [6] Stupp, R., Mason, W.P., Van Den Bent, M.J., Weller, M., Fisher, B., Taphoorn, M.J., Belanger, K., Brandes, A.A., Marosi, C., Bogdahn, U., Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 352:10 (2005), 987–996.
7. [7] Riemenschneider, M., Hegi, M., Reifenberger, G., MGMT promoter methylation in malignant gliomas. Target. Oncol. 5:3 (2010), 161–165.
8. [8] Prayson, R.A., Agamanolis, D.P., Cohen, M.L., Estes, M.L., Kleinschmidt-DeMasters, B., Abdul-Karim, F., McClure, S.P., Sebek, B.A., Vinay, R., Interobserver reproducibility among neuropathologists and surgical pathologists in fibrillary astrocytoma grading. J. Neurol. Sci. 175:1 (2000), 33–39.
9. [9] Zinn, P.O., Majadan, B., Sathyan, P., Singh, S.K., Majumder, S., Jolesz, F.A., Colen, R.R., Radiogenomic mapping of edema/cellular invasion MRI-phenotypes in glioblastoma multiforme. PLoS One, 6(10), 2011, e25451.
10. [10] Zinn, P.O., Sathyan, P., Mahajan, B., Bruyere, J., Hegi, M., Majumder, S., Colen, R.R., A novel volume-age-KPS (VAK) glioblastoma classification identifies a prognostic cognate microRNA-gene signature. PLoS One, 7(8), 2012, e41522.
11. [11] Karnofsky, D.A., Abelmann, W.H., Craver, L.F., Burchenal, J.H., The use of the nitrogen mustards in the palliative treatment of carcinoma. With particular reference to bronchogenic carcinoma. Cancer 1:4 (1948), 634–656.
12. [12] Gutman, D.A., Cooper, L.A., Hwang, S.N., Holder, C.A., Gao, J., Aurora, T.D., Dunn, W.D. Jr., Scarpace, L., Mikkelsen, T., Jain, R., MR imaging predictors of molecular profile and survival: multi-institutional study of the TCGA glioblastoma data set. Radiology 267:2 (2013), 560–569.
13. [13] Colen, R.R., Vangel, M., Wang, J., Gutman, D.A., Hwang, S.N., Wintermark, M., Jain, R., Jilwan-Nicolas, M., Chen, J.Y., Raghavan, P., Imaging genomic mapping of an invasive MRI phenotype predicts patient outcome and metabolic dysfunction: a TCGA glioma phenotype research group project. BMC Med. Genet., 7(1), 2014, 30.
14. [14] Zacharaki, E.I., Morita, N., Bhatt, P., O'Rourke, D., Melhem, E., Davatzikos, C., Survival analysis of patients with high-grade gliomas based on data mining of imaging variables. Am. J. Neuroradiol. 33:6 (2012), 1065–1071.
15. [15] Eoli, M., Menghi, F., Bruzzone, M.G., De Simone, T., Valletta, L., Pollo, B., Bissola, L., Silvani, A., Bianchessi, D., D'Incerti, L., Methylation of O6-methylguanine DNA methyltransferase and loss of heterozygosity on 19q and/or 17p are overlapping features of secondary glioblastomas with prolonged survival. Clin. Cancer Res. 13:9 (2007), 2606–2613.
16. [16] Moon, W.-J., Choi, J.W., Roh, H.G., Lim, S.D., Koh, Y.-C., Imaging parameters of high grade gliomas in relation to the MGMT promoter methylation status: the CT, diffusion tensor imaging, and perfusion MR imaging. Neuroradiology 54:6 (2012), 555–563.
17. [17] Drabycz, S., Roldán, G., De Robles, P., Adler, D., McIntyre, J.B., Magliocco, A.M., Cairncross, J.G., Mitchell, J.R., An analysis of image texture, tumor location, and MGMT promoter methylation in glioblastoma using magnetic resonance imaging. Neuroimage 49:2 (2010), 1398–1405.
18. [18] [ http://cancerimagingarchive.net] TCIA.
19. [19] Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455:7216 (2008), 1061–1068.
20. [20] Bady, P., Sciuscio, D., Diserens, A.C., Bloch, J., van den Bent, M.J., Marosi, C., Dietrich, P.Y., Weller, M., Mariani, L., Heppner, F.L., and others. MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status. Acta Neuropathol. 124:4 (2012), 547–560.
21. [21] Channin, D.S., Mongkolwat, P., Kleper, V., Sepukar, K., Rubin, D.L., The caBIG™ annotation and image markup project. J. Digit. Imaging 23:2 (2010), 217–225.
22. [22] Channin, D.S., Mongkolwat, P., Kleper, V., Rubin, D.L., The annotation and image mark-up project 1. Radiology 253:3 (2009), 590–592.
23. [23] Rubin, D.L., Mongkolwat, P., Channin, D.S., A semantic image annotation model to enable integrative translational research. Summit Translat. Bioinforma., 2009, 2009, 106.
24. [24] Colen, R.R., Wang, J., Singh, S.K., Gutman, D.A., Zinn, P.O., Glioblastoma: imaging genomic mapping reveals sex-specific oncogenic associations of cell death. Radiology 275:1 (2015), 215–227.
25. [25] Bartl, E., Rezankova, H., Sobisek, L., Comparison of classical dimensionality reduction methods with novel approach based on formal concept analysis. Rough Sets and Knowledge Technology, 2011, Springer, 26–35.
26. [26] Wang, Q., Megalooikonomou, V., A dimensionality reduction technique for efficient time series similarity analysis. Inf. Syst. 33:1 (2008), 115–132.
27. [27] Duda, R.O., Hart, P.E., Stork, D.G., Pattern Classification. 2012, John Wiley & Sons.
28. [28] Kohavi, R., John, G.H., Wrappers for feature subset selection. Artif. Intell. 97:1 (1997), 273–324.
29. [29] Hall, M.A., Correlation-Based Feature Selection for Machine Learning. 1999, The University of Waikato.
30. [30] Liu, H., Setiono, R., A Probabilistic Approach to Feature Selection-a Filter Solution. 1996, Citeseer, 319–327.
31. [31] Xu, L., Yan, P., Chang, T., Best First Strategy for Feature Selection. 1988, IEEE, 706–708.
32. [32] Caruana, R., Freitag, D., Greedy Attribute Selection. 1994, Citeseer, 28–36.
33. [33] Laguna, M., Marti, R., Martí, R.C., Scatter Search: Methodology and Implementations in C. 2003, Springer.
34. [34] Martí, R., Laguna, M., Glover, F., Principles of scatter search. Eur. J. Oper. Res. 169:2 (2006), 359–372.
35. [35] Levina, E., Bickel, P.J., Maximum likelihood estimation of intrinsic dimension. Advances in neural information processing systems, 2004, 777–784.
36. [36] Van der Maaten, L., An introduction to dimensionality reduction using matlab. Report, 1201(07-07), 2007, 62.
37. [37] Tenenbaum, J.B., De Silva, V., Langford, J.C., A global geometric framework for nonlinear dimensionality reduction. Science 290:5500 (2000), 2319–2323.
38. [38] Roweis, S.T., Saul, L.K., Nonlinear dimensionality reduction by locally linear embedding. Science 290:5500 (2000), 2323–2326.
39. [39] Belkin, M., Niyogi, P., Laplacian eigenmaps for dimensionality reduction and data representation. Neural Comput. 15:6 (2003), 1373–1396.
40. [40] Scholkopft, B., Mullert, K.-R., Fisher discriminant analysis with kernels. Neural networks for signal processing IX 1:1 (1999), 23–25.
41. [41] H.H. Harman. Modern factor analysis. 1960.
42. [42] Jolliffe, I., Principal Component Analysis. 2002, Wiley Online Library.
43. [43] Agrafiotis, D.K., Stochastic proximity embedding. J. Comput. Chem. 24:10 (2003), 1215–1221.
44. [44] Breiman, L., Random forests. Mach. Learn. 45:1 (2001), 5–32.
45. [45] Cover, T., Hart, P., Nearest neighbor pattern classification. Inf. Theory IEEE Trans. 13:1 (1967), 21–27.
46. [46] John, G.H., Langley, P., Estimating Continuous Distributions in Bayesian Classifiers. 1995, Morgan Kaufmann Publishers Inc, 338–345.
47. [47] Meera Gandhi, G., Srivatsa, S., Adaptive machine learning algorithm (AMLA) using J48 classifier for an NIDS environment. Adv. Comput. Sci. Technol., 3(3), 2010.
48. [48] Schrot, R.J., Ma, J.H., Greco, C.M., Arias, A.D., Angelastro, J.M., Organotypic distribution of stem cell markers in formalin-fixed brain harboring glioblastoma multiforme. J. Neurooncol. 85:2 (2007), 149–157.
49. [49] Costello, J.F., Plass, C., Methylation matters. J. Med. Genet. 38:5 (2001), 285–303.
50. [50] Bruzzone, M.G., Eoli, M., Cuccarini, V., Grisoli, M., Valletta, L., Finocchiaro, G., Genetic signature of adult gliomas and correlation with MRI features. Expert review of molecular diagnostics 9:7 (2009), 709–720.
51. [51] Pope, W.B., Sayre, J., Perlina, A., Villablanca, J.P., Mischel, P.S., Cloughesy, T.F., MR imaging correlates of survival in patients with high-grade gliomas. AJNR Am. J. Neuroradiol. 26:10 (2005), 2466–2474.
52. [52] Hammoud, M., Sawaya, R., Shi, W., Thall, P., Leeds, N., Prognostic significance of preoperative MRI scans in glioblastoma multiforme. J. Neurooncol. 27:1 (1996), 65–73.
53. [53] Lacroix, M., Abi-Said, D., Fourney, D.R., Gokaslan, Z.L., Shi, W., DeMonte, F., Lang, F.F., McCutcheon, I.E., Hassenbusch, S.J., Holland, E., A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J. Neurosurg. 95:2 (2001), 190–198.
54. [54] Ruiz-Ontañon, P., Orgaz, J.L., Aldaz, B., Elosegui-Artola, A., Martino, J., Berciano, M.T., Montero, J.A., Grande, L., Nogueira, L., Diaz-Moralli, S., and others. Cellular plasticity confers migratory and invasive advantages to a population of glioblastoma-initiating cells that infiltrate peritumoral tissue. Stem Cells 31:6 (2013), 1075–1085.
55. [55] Drabycz, S., Roldan, G., de Robles, P., Adler, D., McIntyre, J.B., Magliocco, A.M., Cairncross, J.G., Mitchell, J.R., An analysis of image texture, tumor location, and MGMT promoter methylation in glioblastoma using magnetic resonance imaging. Neuroimage 49:2 (2010), 1398–1405.
56. [56] Eoli, M., Menghi, F., Bruzzone, M.G., De Simone, T., Valletta, L., Pollo, B., Bissola, L., Silvani, A., Bianchessi, D., D'Incerti, L., and others. Methylation of O6-methylguanine DNA methyltransferase and loss of heterozygosity on 19q and/or 17p are overlapping features of secondary glioblastomas with prolonged survival. Clin. Cancer Res. 13:9 (2007), 2606–2613.
57. [57] Korfiatis, P., Kline, T.L., Coufalova, L., Lachance, D.H., Parney, I.F., Carter, R.E., Buckner, J.C., Erickson, B.J., MRI texture features as biomarkers to predict MGMT methylation status in glioblastomas. Med. Phys. 43:6 (2016), 2835–2844.
58. [58] Levner, I., Drabycz, S., Roldan, G., de Robles, P., Cairncross, J.G., Mitchell, J.R., Predicting MGMT methylation status of glioblastomas from MRI texture. International Conference on Medical Image Computing and Computer-Assisted Intervention, 2009, Springer, Berlin Heidelberg, 522–530.